Cargando…
A UK Single-Center, Retrospective, Noninterventional Study of Clinical Outcomes and Costs of Two BotulinumtoxinA Treatments for Limb Spasticity
Service model changes at the North Staffordshire Rehabilitation Centre (UK) included switching spasticity treatment from onabotulinumtoxinA (onaBoNT-A) to abobotulinumtoxinA (aboBoNT-A). This noninterventional, retrospective, longitudinal study (NCT04396704) describes the clinical and economic outco...
Autores principales: | Bezzina, Clive, Degtiar, Vadim, Danchenko, Natalya, Maisonobe, Pascal, Davis, Benjamin, Engmann, Emanuel, Guyon, Elodie, Lecanuet, Sophie, Whalen, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534376/ https://www.ncbi.nlm.nih.gov/pubmed/37755958 http://dx.doi.org/10.3390/toxins15090532 |
Ejemplares similares
-
Impact of Neu-botulinumtoxinA on the Severity and Quality of Life of Cervical Dystonia Patients
por: Jagota, Priya, et al.
Publicado: (2016) -
Combined treatment of botulinumtoxin and robot-assisted rehabilitation therapy on poststroke, upper limb spasticity: A case report
por: Lee, So Young, et al.
Publicado: (2017) -
Botulinum Toxins Type A (Bont-A) in the Management of Lower Limb Spasticity
in Children: A Systematic Literature Review and Bayesian Network
Meta-analysis
por: Guyot, Patricia, et al.
Publicado: (2019) -
THE SPASTICITY-RELATED QUALITY OF LIFE 6-DIMENSIONS INSTRUMENT IN UPPER-LIMB SPASTICITY: PART I DEVELOPMENT AND RESPONSIVENESS
por: TURNER-STOKES, Lynne, et al.
Publicado: (2021) -
THE SPASTICITY-RELATED QUALITY OF LIFE 6-DIMENSIONS INSTRUMENT IN UPPER-LIMB SPASTICITY: PART II A FIRST PSYCHOMETRIC EVALUATION
por: TURNER-STOKES, Lynne, et al.
Publicado: (2021)